<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 259 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page258.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=259">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 259 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 259</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=259"><img src="../thumb/259.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>222 / 2020-04                                                            Genital System - 17.5.2
   deform.of penis, bleed.disords., pept. ulcerat., fact.incr.plasma lev.  Indications: Erectile dysfunct.(sex.stimulat.reqd.)  (S4) TABS, [P/S] 36/7.1.5/0515, 0516, 0517
   are age&gt;65 yrs./ hepat.impairm., sev.ren.impairm./concom.potent   (S4) TABS. 36/7.1.5/0385  701067-001: 5 mg, 4, R152,06
   cytochrome P450 3A4 inhibit.theref.consid. low.init.dos., protect.  720345-002: 20 mg, 2, R403,57  701069-001: 10 mg, 2, R152,06
   against STD’s incl.HIV & pregn.  720345-001: 20 mg, 4, R201,76  701069-002: 10 mg, 4, R304,15
   Drug interactions: Clear.reduc.by inhibit of cytochrome P450 & iso-  Dosage: Adult men: Recomm.max:20 mg. Max. dos. freq: once   701071-003: 20 mg, 2, R303,78
   forms 3A4 & 2C9, HIV prot.inhibit.eg saquinavir reduc.clear., ritonavir   dly. It can be taken 36 hrs.and as early as 16 mins.prior to sex.activ.  701071-001: 20 mg, 4, R607,59
   incr plasma conc., potent.hypotens.eff.of nitr.  Contraindications: Concomit.organ.nitrate of any form, sev.  (S4) ORODISPERS.TABS, [P/S] 44/7.1.5/1049
   CAVERJECT, Pfizer [P/S]      hepat.insuffic., loss of vis.in one eye because of non-arterit.anter.  717985-001 :10 mg, 4, R330,53
                                                              Dosage: Oral use. Sexual stimulat.reqd. Max. freq. once/day.
                                ischaem.opt. neuropathy (NAION) regardless if episode was in/
   Alprostadil.                 not in connect with prev.PDE5 inhibit.expos., safety & effic.in   Recomm. init.dos: 10 mg approx. 1 hr bef.sex. activ. but may be tak.
   Indications: Erect.dysfunct.in adult males, adjunct in diagn.of   pregn.& lactat.not est., safety & effic. of combinat.with other erect.  anywhere betw. 25 mins.-4-5 hrs bef. Recomm.dos.range is 5-20 mg
   erect.dysfunct.              dysfunct.treatm. not est.& theref.not recomm.  bas.on tolerab.& effic.
   (S4) INJ. 28/7.1/0329. 20 µg.  Side effects: V.common: Headache. Common: Flush., dyspeps.,   Orodispers tabs: Place on tong.without food/liq. in mouth. Admin.
   821764-004: Sngl.dos.vial & pre-fill.syr, R213,40          immed.upon release from blist.
   Dosage: Admin.by direct intracavernos.inj.along dorso-lat.aspect   back pain, myalg., dizzin., nas. congest. Uncommon: Conjunctiv.  Contraindications: Concom.nitrate/nitric oxide donors, women,
                                hyperaem., eye pain, eyelid swell. Freq.unknown: Hypersens.
   of proxim.third of penis. Indiv. dos. to produc.erect.of a durat.not   childr., neonates, end-stage ren. dis. req.dialys., penile anatomic.
   exceed. 1 hr.                reacts., fac.oed., Stev.John.syndr., exfoliat. dermatit., ser.CV &   deformat., condit. predispos. to priapism, hypotens.(rest.systol.BP
                                cerebrovasc.events main.in pts. report.pre-exist.CV risk fact.,
   Dos.range: 10-20 µg. Dos.exceed.60 µg not recomm.
   Diagnos. No evid.of neurolog.dysfunct: 20 µg into corpus caver-  hypo-/hypertens., syncope, abdom.pain, gastroesophag.reflux.,   of &lt;90mmHg), uncontr.hypertens. (&gt;170/110mmHg), stroke/ life
                                                              threat.arrhythm.hist., MI within last 6 mnths., uncontr.CF, unstab.
                                sweat., blurr.vis., irrevers.uni/bilater.non-arteritic. anter. ischaem.
   nosum and massaged through penis. Evid.of neurologic.dysfunct:
   Init 5 µg but must not exceed 10 µg.  optic neuropathy, retin.vein occlus., vis. field defect, sudd.uni-/bilat.  ang., known heredit. degenerat. retin.disords., bleed.disords., act.
                                                              pept. ulcerat., sev.liv.impairm., concom.indinavir & ritonavir, men with
   Erect.dysfunct.of vasculogen., psychogen./ mix. aetiology:   decr.or loss of hear., priapism, migraine, epistax
   Init: 2,5 µg. Second dos.of 5 µg if there is partial respons.& 7,5 µg if   Warnings and special precautions: Pre-exist. card. dis.where   underly.card.condits.for whom sex. activ.is not recomm., other erect.
                                                              dysfunct. treatm. not stud., concom.indinavir/ritonavir, congenit. QT
   no respons. Subseq. increm.incr.of 5-10 µg until optim.dos. If there is   sex.activ.is inadvis.due to potent. card. risk, seek medic.advice
   no respons.to admin.dos.the next high. dos may be given within 1 hr.   for erect.&gt; than 4 hrs., CV dis pts.not incl.in clinic.trials incl: MI   prolongat., concom.Class 1A or Class lll antiarrhythm., concom.itra-
                                                              conazole/ ketoconazole dos.high.than 200 mg, also Orodispers. tabs:
   At least 1 day interval bef.next dos.if response noted   within last 90 days/unstable ang.or ang.occur.dur. sex. intercourse/
   Pure neurogen.(spin.cord injury): Init. 1,25 µg may be incr.to   NYHA Class 2 or great.HF in last 6 mnths./ uncontroll. dysrhythm./  not recomm.in mod.hepat. impairm., phenylketonur., rare heredit.fruct.
   2,5 µg, follow.by a dos.of 5 µg and then in 5 µg increm.until dos.  hypotens. (&lt;90/50 mm Hg/uncontrol.hypertens.& stroke within   intol., concom. Orodispers.tabs.as start.dos.in pts.on alpha-blocks.
   produc.erect.not exceed.a durat.of 60 mins. If there is no respons. to   last 6 mnths., med.assessm.to determ. poss. underly.causes &   Side effects: Incr.QTc-interv., headache, dizzin., vasodilat., nas./sinus
   admin.dos.the next high.dos may be given within 1 hr. At least 1 day   appropr.treatm.thereof, consid. cardiovasc. stat./risk, advis.pts.to   congest., GI disturbs.incl. GORD, back/abdom./eye/back/chest pain,
   interval bef.next dos.if response noted. Max.freq.is not more than   discont. ther. & seek med.advice if sudd.loss of vis./hear. decr. or   incr. musc. tone & cramp., incr.creatine kinase, conjunctivit., allerg.
   once dly and no more than 3x/wk.  loss exper., avoid future tadalafil/other PDE5 inhibit. use in case of   react., angioed., paraesthes., dysesthes., somnol., syncope, amnes.,
   Contra-indications: Condits.predispos.to priapism, anatom.deform.  NAION, condits. predispos. to priapism, anatomic.deform.of penis,   seiz., vis. disturbs. incl.vis.loss, rais.IOP, photophob., tinnit., vertigo,
   of penis, penile implant, where sex.activ.is medic.inadvis., women,   concom. alpha-1-block.eg doxazosin, eval risk of poss. advers. eff.  palpitat., tachycard., ang.pect., MI, ventr. tachyarrythm., hypotens.,
   childr., newborns.           from vasodilat.eff., galact./ lact. intol.  dyspn., skin reacts., myalg., incr.erect., priapism, feel.unwell., non-
   Side-effects: Penile pain, painf.erect.in pts.with anatom.deformat.,   Interactions: BP low.eff.of doxazosin (alpha1-adrenerg.block)   arterit. anter. ischaem.optic neuropathy.
   haematoma at inj.site, loc. reacts., prolong.erect./priapism, syst.effs.  augment., ketoconazole incr.sngl. dos. expos/C max., ritonavir a   Special precautions: Assess card.status prior to any treatm., max.
   such as testicul.pain/swell., scrot.erythem., pain/tightn., urin. freq./   CYP3A4/2C9/2C19 & 2D6 inhibit. incr.sngl.dos.expos.theref.  of 5 mg not exceed.with concom. ketoconazole/ itraconazole/eryth-
   urgency, imp.urinat., hypo./hypertens., vasodilat., supraventric.extra-  simil.eff. can be expect.with other HIV protease/CYP3A4 inhibit.,   romycin/ clarithromycin, known/congenit.QT prolongat. hist./ con-
   syst., periph.vasc disord., dizzin., hypaesthes., loc.pain, headache, flu   rifampicin a CYP3A4 induc.reduc.sngl.dos. expos. /C max.theref.  com.meds.known to prolong QT interv., discont. ther.immed.& alert
   syndr., back pain, buttock weakn.  simil.eff.can be expect.with other induc., antihypertens.agents eff.  physic.in case of sudd. vis. loss, with concom.alpha-block.ther.init.at
   Special precautions: Report.prolong.erect.(4 hrs/ long.)&/pria-  poss. augment., augments hypotens.eff.of nitrates, antacids reduc.  low. recomm. start.dos.of 5 mg only if pt.stable on alpha-block. ther.,
   pism, reg.follow up exam.to detect. penile fibros., pts.on anticoags.  absorpt.without alter.AUC expos.  consid.time separat.dose with concom. alpha-block.except tamsulo-
   may have incr. propens.for bleed.aft.inj., diagn.& treat any underly.   See also MDR page 165.  sin, elderly &gt;65 yrs., sudd.deafn./hear.loss, non-arterit.anter. ischaem.
   medic.causes of erect.dysfunct.prior to therapy, poss.incr.transmiss.  DYNAFIL, Pharma Dynamics [P/S]  optic neuropathy risk fact.
   of bld.born dis.due to poss. bleed.induc.by inj.           Interactions: Cytochrome P450 (CYP) 3A4 inhibit. incr.plasma lev.,
                                Sildenafil citr.              poss.symptomat.hypotens.with alpha-block., furth.low.BP with grad.
   CIALIS, Eli Lilly [P/S]      Indications: Erectile dysfunct.  alpha-block incr. in pts.taking PDE5 inhib., hypotens.eff.of subling.ni-
   Tadalafil.                   (S4) TABS. A42/7.1.5/1071, 1072  troglycer.potent., incr.AUC & Cmax with erythromycin/ketoconazole/
   Indications: Erectile dysfunct.(sex.stimulat. reqd.)  718397-001: 50 mg, 4, R70,14  indinavir/ritonavir.
   (S4) TABS. 36/7.1.5/0384     718397-002: 50 mg, 12, R210,45
   700204-001: 20 mg, 2, R266,72  718396-001: 100 mg, 4, R140,30  RAVIAG, Ranbaxy [P/S]
   700204-002: 20 mg, 4, R533,52  718396-002: 100 mg, 12, R420,91  Sildenafil
   Dosage: Recomm.max:20 mg prior to anticipat. sex.activ.up to 36 hrs.  Dosage: 50 mg approx.1 hr.bef.sex.activ. May be incr.to 100 mg or   Indications: Erectile dysfunct.
   or 16 min.prior to sex. activ. Max. dos freq is once dly.  decr.to 25 mg depend.on effic.& tol. Max.recomm.dos.is 100 mg &   (S4) TABS. 45/7.1.5/0873, 0874
   (S4) TABS, 41/7.1.5/0644     max.dos.freq.is 1xdly.        721402-001: 50 mg, 4, R72,33
   713444-001: 5 mg, 28, R1 042,13  Contraindications: Concom.nitric oxide donors/ nitrat./ritonavir,   721403-001: 100 mg, 4, R144,69
   Dosage: Adult men: 2,5-5 mg once dly.at approx. same time   safety & effic.of combinat.with other treatm.of erect.dysfunct.not   Dosage: Adults: 50 mg once dly.admin. 1 hr.bef. sex.activ. May be
   each day.                    stud., men in whom sex.activ.is inadvis., galact.intol.hist., Lapp lact.  incr.to 100 mg or decr.to 25 mg depend. on effic.& tol. Max.dly.dos:
   Contraindications: Concomit.organ.nitrate of any form, sev.ren./  defic., gluc.galact. malabsorpt., women & childr.  100 mg. Dos. freq. once/day.
   hepat.insuffic., loss of vis.in one eye because of non-arterit.anter.is-  Side effects: Deafn., temp.vis.loss/disturbs., epistax., bld.dyscras.,   Contraindications: Concom.nitric oxide donors/ nitrat., sev.ren./
   chaem. opt. neuropathy regardless if episode was in/not in connect   allerg./photosens.react., thirst, gout, unstab.diab., hyperglycaem.,   hepat.impairm., concom.potent cytochrome P450 3A4 inhib.
   with prev.PDE5 inhibit.expos., men with card.dis.for whom sex.activ.  periph./ fac./genit.oed., hyperuricaem., hypoglycaem. react., hy-  Side effects: Ser.CV events incl.MI/sudd.card. death/ CV haemor-
   is inadvis., safety & effic.in pregn.& lactat.not est., safety & effic.of   ponatraem., depress., insomn., headache, dizzin., atax., hyperton.,   rh./TIA, hypertens., flu syndr., RTI, H simplex., pharyngit., bronchit.,
   combinat.with other treatm.of erect. dysfunct. not est.& theref.not   neuralg., neuropathy, paraesthes., trem., vertigo, somnol., abnorm.   sinusit., UTI, laryngit., bld.dyscras., allerg./hypersens.reacts., gout,
   recomm.2,5 mg & 5 mg tabs.also: prev.part./sudd./tempor.or perman.   dreams, decr.reflex., hypoaesthes., ocul.burn./ swell., incr.IOP, retin.  unstab.diab., hyperglycaem., hyperuricaem., hypoglycaem.react.,
   decr.or loss of vis.in one or both eyes, prev. uni-/bilat.hear.decr.or loss   vasc.dis./bleed., vitreous detach./tract., paramacul.oed., conjuctiv.,   hypernatraem., psych./card. /prostat./ren./urin./resp.disords., anor-
   thereof with/ without assoc.vestibul.sympts., galact.intol/ Lapp lact.   photophob., eye haemorrh., cataract, dry eyes/ mouth, mydrias., di-  gasm., headache, dizzin., CNS/vasodilat.effs., neuropathy, trem., ver-
   defic./gluc.-galact.malabsorpt.  plop., tinnit., eye/chest/ear/ abdom.pain, ser.CV events incl.MI &   tigo, decr.reflex., migraine, myasthen., seiz./ recurr.thereof, eye dis-
   Side effects: Flush., dyspeps., back pain, myalg., headache, dizzin., nas.  cerebrovasc. haemorrh./sudd.death, syst.vasodil.eff.poss. result.in   ords.incl.chromatops., eye haemorrh., cataract, eye/ear/bone/limb/
   congest., conjunctiv. hyperaem., eye pain, eyelid swell., hypersens. re-  trans.supine BP, ventr.arrythm., TIA, ang.pect., AV block, migraine,   back/ chest pain, temp.vis.loss, ocul.redn./burn./swell., incr.IOP, retin.
   acts., Stev.John.syndr., exfoliat. dermatit., ser.CV & cerebrovasc.events   palpit., CF, abnorm. ECG, cardiomyopathy, hypo-/hypertens., syncope,   vasc.dis./bleed., vitr.detachm./tract. & paramacul.oed., non-arter.ant.
   main.in pts.report.pre-exist.CV risk fact., hypo-/hypertens., syncope, ab-  nas.congest., dyspn., asthma, laryngit., pharyngit., sinusit., bronchit.,   ischaem. opt. neuropathy lead.to poss.perm.vis.loss, tinnit., deafn.,
   dom.pain, gastroesophag. reflux., sweat., blurr.vis., irrevers. uni/bilater.  incr.cough/sputum, dyspeps., GI disturbs.incl.rect.haemorrh., glossit.,   flush., hypotens., shock, epistax., postur. hypotens., rhinit., asthma,
   non-arteritic.anter.ischaem. optic neuropathy, retin.vein occlus., vis.field   dysphag., stomatit., gingivit., abnorm.liv.funct.tests, flush., erythem.,   dyspn., incr.cough/ sputum, GI disturbs., rect.haemorrh., gingivit., skin
   defect, sudd.uni-/bilat.decr.or loss of hear., priapism, migraine, epistax  skin reacts.incl.exfolat.dermatit., H.simplex, sweat., skin ulc., myalg.,   reacts. incl.exfol.dermatit., fac./genit./periph.oed., alopec., cellulit.,
   Special precautions: Use not recomm.in MI within last 90 days/  arthrit., arthros., tend.rupt., tendosynovit., myasthen., cystit., synovit.,   sweat., arthrit., arthros., arthralg., myalg., tend.rupt., tenosynovit.,
   unstable ang./ang.occur.dur. sex.intercourse/NYHA Class 2 or great.  noctur., urin.freq./incont., haematur., priapism, breast enlargem.,   synovit., haematur., cystit., abnorm.ejaculat., breast enlargem., as-
   HF in last 6 mnths./uncontroll.dysrhythm./hypotens./ uncontrol. hy-  abnorm. ejaculat., anorgasm., fev., shock, asthen., accid.fall /inj.  then., photosens., thirst, chills, abnorm. LFT/ECG, accident.fall/inj.
   pertens.or stroke within last 6 mnths., concom.antihypertens.treatm.,   Special precautions: Pre-exist.card.dis.risk, thorough med.hist.&   Warnings and special precautions: Not an aphrodisiac, pts.old.
   med. assessm. to determ.poss.underly.causes & appropr. treatm.  physic.exam.diagn. erect. dysfunct., consid.CV status, MI/stroke/  than 65 yrs., pre-exist.card. dis. risk, where sex.activ.is inadvis.due to
   thereof, consid.cardiovasc.stat./ risk, advis.pts.to discont.ther.& seek   life threat. arrhythm. with.last 6 mnths., rest.hypotens./ hypertens.,   underly. CV status, med.hist.& physic.exam.diagn.erect. dysfunct. bef.
   med.advice if sudd.loss of vis./hear.decr.or loss exper., seek medic.   CF/ cor.artery dis.caus.unstab.ang., retinit. pigmentosa, medic.ad-  init.ther., left ventric.outflow obstruct., syndr.of multip.syst.atrophy, 1   st
   advice for erect.&gt; than 4 hrs., condits. predispos. to priapism, ana-  vice for erect.&gt; than 4 hrs, condits.predispos.to priapism, anatomic.   stabil. pts. on alpha block.ther.bef.init.ther., postur. hypotens. sympt.,
   tomic.deform.of penis, concom.alpha-1-block.eg doxazosin, eval risk   deform. of penis, concom.other antihypertens., bleed. disords., pept.  MI/stroke/life-threat.dysrhythm. with. last 6 mnths., rest.hypotens.
   of poss. advers.eff.from vasodilat.eff.  ulcerat., fact.incr.plasma lev. are age&gt;65 yrs./hepat.impairm./sev.  (BP &lt;90/50) or hypertens. (BP &gt;170/110 ), card.fail./coron.arter. dis.
   Drug interactions: Tadalafil expos.incr.by ketoconazole a select.  ren. impairm./ concom. potent cytochrome P450 3A4 inhibit. theref.   caus.unstab.angin., retinit.pigmentosa, medic. advice for erect.&gt; than
   inhibit.of CYP3A4, ritonavir a CYP3A4/2C9/2C19 & 2D6 inhibit.incr.   consid.low.init.dos.  4 hrs./priapism, penis deformat., condits.predispos.to priapism, safety
   sngl.dos. expos.theref.simil.eff.can be expect.with other HIV pro-  Drug interactions: Potent. hypotens.eff.of nitrates, reduc.clear.  & effic. with other concom.ther.for erect.dysfunct. not est., interacts.
   tease/CYP3A4 inhibit., rifampicin a CYP3A4 induc.decr.plasma conc   with inhib.of cytochrome P450 (CYP) isoforms 3A4 & 2C9, ritona-  with concom.other antihypertens. not studied, bleed.disords., act.
   theref.simil.eff. can be expect.with other induc., antihypertens. agents   vir incr plasma conc., incr.metab./clear.with induc.of cytochrome   pept. ulc., not for use in childr./women/NAION risk fact., mild-mod.
   eff.poss.augment., BP low.eff.of doxazosin (an alpha1-adrenerg.block)   P450 (CYP) isoforms 3A4 eg.rifampic., antihypertens. eff.of other   ren./hepat.funct.impairm., safe admin.of nitrates 24 hr post dos.un-
   augment., potent. hypotens.eff.of nitr., antacids reduc. absorpt. with-  antihypertens.potent.  known in pts. &gt;65 yrs./hepat.impairm./sev.ren.impairm.or concom.
   out alter.AUC expos.                                       P450 3A4 inhibit.as conc.3-8xhigh.than seen in healthy volunteers.
                                LEVITRA, Bayer [P/S]          Drug interactions: Potent.hypotens.eff.of ac./ chron. nitrat., poss.
   CIAVOR 20, (Aspen Pharmacare) Eli Lilly [P/S] &  Vardenafil  symptom.hypotens.with alpha-blocks., anti-aggregat.eff.of sod.ni-
   Tadalafil.                   Indications: Erectile dysfunct.  tropruss. potent., hypotens.events with alpha blocks., incr. plasma</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page258.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>&nbsp;&nbsp;&nbsp;<a href="page255.html">255</a>&nbsp;&nbsp;&nbsp;<a href="page256.html">256</a>&nbsp;&nbsp;&nbsp;<a href="page257.html">257</a>&nbsp;&nbsp;&nbsp;<a href="page258.html">258</a>&nbsp;&nbsp;&nbsp;<a href="page259.html">259</a>&nbsp;&nbsp;&nbsp;<a href="page260.html">260</a>&nbsp;&nbsp;&nbsp;<a href="page261.html">261</a>&nbsp;&nbsp;&nbsp;<a href="page262.html">262</a>&nbsp;&nbsp;&nbsp;<a href="page263.html">263</a>&nbsp;&nbsp;&nbsp;<a href="page264.html">264</a>
             </td>
             <td width="35%"><a href="page260.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page260.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
